Joshua Smiley
Presidente en ZAI LAB LIMITED .
Fortuna: 59 291 $ al 31/05/2024
Perfil
Actualmente, Joshua L. Smiley es tesorero, director y vicepresidente de CoLucid Pharmaceuticals, Inc. El Sr. Smiley también forma parte del consejo de la Universidad de Butler y de la Fundación Eskenazi Health. En su anterior carrera profesional fue Director Financiero y Vicepresidente Senior de Eli Lilly & Co. y Director Financiero, Contralor y Vicepresidente Senior de Finanzas de Lilly Research Laboratories (una filial de Eli Lilly & Co.). Joshua L. Smiley se licenció en la Universidad de Harvard.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
ZAI LAB LTD.
0.00% | 13/05/2024 | 31 684 ( 0.00% ) | 59 291 $ | 31/05/2024 |
Cargos activos de Joshua Smiley
Empresas | Cargo | Inicio |
---|---|---|
ZAI LAB LIMITED | Presidente | - |
Butler University | Director/Miembro de la Junta | - |
Eskenazi Health Foundation | Director/Miembro de la Junta | - |
Unseen Capital LLC
Unseen Capital LLC Investment ManagersFinance Unseen Capital LLC (Unseen Capital) is a venture capital firm founded in 2020 by Warnell Kayode Owens. The firm is headquartered in New York. | Consultor / Asesor | - |
Antiguos cargos conocidos de Joshua Smiley.
Empresas | Cargo | Fin |
---|---|---|
ELI LILLY AND COMPANY | Director Financiero/CFO | 09/02/2021 |
ELANCO ANIMAL HEALTH INCORPORATED | Director/Miembro de la Junta | 11/03/2019 |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Director Financiero/CFO | 01/01/2015 |
COLUCID PHARMACEUTICALS INC | Director/Miembro de la Junta | - |
Gilead Connecticut, Inc.
Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Director/Miembro de la Junta | - |
Formación de Joshua Smiley.
Harvard University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
ELANCO ANIMAL HEALTH INCORPORATED | Health Technology |
ZAI LAB LIMITED | Health Technology |
Empresas privadas | 5 |
---|---|
Gilead Connecticut, Inc.
Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Health Technology |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
CoLucid Pharmaceuticals, Inc.
CoLucid Pharmaceuticals, Inc. BiotechnologyHealth Technology CoLucid Pharmaceuticals, Inc. engaged in the development of therapeutics for neurological disorders. Its products included Lasmiditan, a neurally acting anti-migraine agent that is designed to delivered efficacy in migraine without the vasoconstrictor activity associated with previous generations of migraine therapies and a Conjugated Stigmines platform that has generated a series of preclinical candidates for the chronic pain, Alzheimer's disease and psychiatric disorders. The company was founded by James F. White and Arthur M. Pappas in 2005 and was headquartered in Cambridge, MA. | Health Technology |
Eskenazi Health Foundation | |
Unseen Capital LLC
Unseen Capital LLC Investment ManagersFinance Unseen Capital LLC (Unseen Capital) is a venture capital firm founded in 2020 by Warnell Kayode Owens. The firm is headquartered in New York. | Finance |
- Bolsa de valores
- Insiders
- Joshua Smiley